When multi-marker Down syndrome screening began the focus was in the second trimester using: hCG or free β-hCG and AFP (“Double” test); plus uE3 (“Triple” test); or both uE3 and inhibin A (“Quad” test). Here, AFP is linked to Down syndrome.